Skip to content
triangle-white-good

FEATURED ARTICLE

From ACRP Blog: "Obstacles Slow Optimal Real-World Data Adoption in Clinical Trials"

FEATURED ARTICLE

From ACRP Blog: "Obstacles Slow Optimal Real-World Data Adoption in Clinical Trials"

VIEW BY
second-menu-section

NEWS PAGE

14 February, 2020

Life Sciences Industry Rapidly Adopting Real-World Data, but Access to Robust Data a Concern/Barrier, According to Inteliquet Survey

READ MORE

07 November, 2019

Inteliquet Achieves Milestone in Modernizing Patient Recruitment For Clinical Trials: 250 Digitized Trials Enabling 1000 Patients to be Identified for Clinical Trials

Inteliquet, a leading provider of intelligent technology, insights and services for optimizing clinical trials and research, has reached a significant milestone. Working in close collaboration with cancer centers in its Clinical Consortium, Inteliquet has digitized more than 250 clinical trial protocols and proactively identified 1000 patients eligible for participation in oncology clinical trials. This directly led to 834 patients to be enrolled in a clinical trial that they otherwise would have missed.Inteliquet also welcomes industry veteran Marie E. Lamont as Interim President and COO. Lamont was formerly President of the Patient Services Business Unit at Dolman Life Science Services, a commercial services provider to the life sciences industry.
READ MORE

24 July, 2019

From Managed Healthcare Executive: “We Need a Better Clinical Trial Recruitment Process”

CEO Carla Balch notes that"being data-driven isn't enough to improve the scale and precision of clinical trials." Find out why.
READ MORE

15 July, 2019

ASCO 2019: CEO Carla Balch Discusses How to Achieve Clinical Trial Success

At ASCO 2019, CEO Carla Balch sat down with Oncology Central. She discussed how Inteliquet brings "one source of truth" to the stakeholders of clinical trial process, including Pharma, CROs, patients, and providers.
READ MORE

07 June, 2019

From Biocentury.com: ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

Staff Writer Allison Johnson speaks to CEO Carla Balch about how drug developers can match more patients to clinical trials by broadening eligibility criteria and encouraging trial enrollment in community settings.
READ MORE

INTELIQUET MEDIA CONTACT

Dorit Baxter, Senior Vice President of Marketing

Inteliquet

Phone: (401) 871-0734

Email: dbaxter@inteliquet.com

LEARN MORE

Would you like a demo? More information? Let us know how we can help. We’ll contact you shortly.